Standard Biotools | FLDM - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Agilent USD 1.44B 27M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Bruker USD 900.9M 124.3M 2025-12
Danaher USD 5.34B 45.74B 2025-12
Illumina USD 903M 69M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
Nikon Corporation JPY 269.8B 111.36B 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sony JPY 3.2T 1.57T 2025-12
Standard Biotools USD 45.72M 2.7M 2025-12
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Waters USD 661.85M 1.67B 2025-12